Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Battle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agentMark R Battle, Julian L Goggi, Lucy Allen, et al.
EJNMMI Research|December 7, 2018
Centiloid scaling for quantification of brain amyloid with [<sup>18</sup>F]flutemetamol using multiple processing methodsMark R Battle, Lovena Chedumbarum Pillay, Val J Lowe, et al.
Nuclear Medicine and Biology|July 30, 2013
Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brainMelissa E Rodnick, Brian G Hockley, Phillip Sherman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
Nuclear Medicine and Biology|February 1, 2014
Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptorAlexander Jackson, Mark R Battle, Dennis M O'Shea, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptorAlexander Jackson, Benedicte B Guilbert, Stuart D Plant, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agentMark R Battle, Julian L Goggi, Lucy Allen, et al.
EJNMMI Research|December 7, 2018
Centiloid scaling for quantification of brain amyloid with [<sup>18</sup>F]flutemetamol using multiple processing methodsMark R Battle, Lovena Chedumbarum Pillay, Val J Lowe, et al.
Nuclear Medicine and Biology|July 30, 2013
Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brainMelissa E Rodnick, Brian G Hockley, Phillip Sherman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
Nuclear Medicine and Biology|February 1, 2014
Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptorAlexander Jackson, Mark R Battle, Dennis M O'Shea, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptorAlexander Jackson, Benedicte B Guilbert, Stuart D Plant, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
Pageof 1